Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

NATHAN ALLAN LACK

Doçent

Koç Üniversitesi Tıp Fakültesi Dahili Tıp Bilimleri Bölümü

Research topics OpenAlex
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Biyoloji
Articles 20 YÖKSİS 20 · OpenAlex 0 Total citations 1,749 h-index 22 · OpenAlex Q1 articles 14 Scopus · WoS Q1 12 Best field rank #12,498 / 39,749 Main field · top 31.4% Co-authors 91 0 Turkish institutions

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 18 + YÖKSİS · co-author record: 17
h-index 22 Percentile in Türkiye: 96 #82 of 453 at their university by h-index
i10-index
27
Total citations
1,749
Top 4.5% in Türkiye
Per article
50.0
FWCI
3.24
1.00 = world average
World top 1%
1
World top 10%
9

Most cited articles

  1. Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells 2015 world top 1% 397 citations
  2. A CD74 dependent MHC class I endolysosomal cross presentation pathway 2012 world top 10% 152 citations
  3. Arylamine N acetyltransferases structural and functional implications of polymorphisms 2008 world top 10% 132 citations
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 17 articles (694 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
91
With an akaturk profile
0
Turkish institutions
0
Co-authored works
%100

Academic co-authors 0

No co-author with an akaturk profile.

National collaboration 0 institutions

No joint work with another Turkish university.

Other co-authors (incl. international) 91

Lack NA 14Sim E 9Axerio-Cilies P 4Guns ET 4Leblanc E 4Rennie PS 4Westwood IM 4Cherkasov A 3Evangelopoulos D 3Fullam E 3Bhakta S 2Chan KH 2Eltis LD 2Frewin K 2Hassona MD 2Kawamura A 2Li H 2Long H 2Lowe ED 2Noble ME 2Sim RB 2Singh K 2Abdelbaqi KAbuhammad AAcar OAdomat HBadel KBan FBasha GBeard SBohm KJBowdish DMEBridgerCalandra GBCarroll MVChavez-Steenbock AChoi KBDale DCDunn CDEsen T

Show all (91)

GA.Garipler GGordon SGreen BGupta AGuy RKHalliday ACHan FQHill AVSHill PCHorsman GPJefferies WAKanaan NKendall SKnight MKotha LKrylova ALabriere CLaurieri NLee HLiles WCLiu JLowe E and Churchill GCMacFarland RTMaitra AMunuganti RSMutlu NNewport MOmilusik KOwen RPrinz HReinicke ATRussell AJSafe SJSakamoto KSanderson TSandy JSchweichler JShashi Nayana MRSingh NSirugo GStaunton DTavassoli PTomlinson-Guns EVannberg FOWakefield LWang CJYam KCYeung AYoung Rten Bokum AMC

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Indexes and citation percentiles

?
TR Index 0 articles
OpenAlex citation percentile
Top 1%0
Top 10%7
Avg · n 19 %85.7
Other counts

Scopus (SJR)

  • YÖKSİS rows 19

WoS (JCR)

  • YÖKSİS rows 20

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

20articles

Journals with publications

18 journals

Narrow down

Scopus (SJR)
Q114 Q25 Q30 Q40
WoS (JCR)
Q112 Q25 Q32 Q41
TR Index
0articles

Article list

  1. 2014 Deletion of conserved protein phosphatases reverses defects associated with mitochondrial DNA damage in Saccharomyces cerevisiae PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA DOI 10.1073/pnas.1312399111 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.2%
  2. 2014 Characterisation of a putative AraC transcriptional regulator from Mycobacterium smegmatis TUBERCULOSIS DOI 10.1016/j.tube.2014.08.007 YÖKSİS SJR Q1 JCR Q2 OpenAlex 65.7%
  3. 2013 New therapeutics to treat castrate resistant prostate cancer Scientific World Journal DOI 10.1155/2013/379641 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 90.8%
  4. 2013 Characterization of a new class of androgen receptor antagonists with potential therapeutic application in advanced prostate cancer MOLECULAR CANCER RESEARCH DOI 10.1158/1535-7163.MCT-13-0267 YÖKSİS SJR Q1 JCR Q1 OpenAlex 80.4%
  5. 2013 Targeting the Binding Function 3 BF3 Site of the Androgen Receptor Through Virtual Screening 2 Development of 2 2 phenoxyethyl thio 1H benzimidazole Derivatives JOURNAL OF MEDICINAL CHEMISTRY DOI 10.1021/jm3015712 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.9%
  6. 2013 Genetic variants of MARCO are associated with susceptibility to pulmonary tuberculosis in a Gambian population BMC Medical Genetics DOI 10.1186/1471-2350-14-47 YÖKSİS SJR Q2 JCR Q3 OpenAlex 79.8%
  7. 2012 Cloning expression purification crystallisation and X ray analysis of inositol monophosphatase from Mus musculus and Homo sapiens ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS DOI 10.1107/S1744309112035191 YÖKSİS JCR Q1 OpenAlex 72.3%
  8. 2012 Targeting the Binding Function 3 BF3 Site of the Human Androgen Receptor Through Virtual Screening JOURNAL OF MEDICINAL CHEMISTRY DOI 10.1021/jm200532b YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.0%
  9. 2012 A CD74 dependent MHC class I endolysosomal cross presentation pathway NATURE IMMUNOLOGY DOI 10.1038/ni.2225 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.1%
  10. 2011 Antiandrogenic and growth inhibitory effects of ring substituted analogs of 3 3 diindolylmethane ring DIMs in hormone responsive LNCaP human prostate cancer cells PROSTATE DOI 10.1002/pros.21356 YÖKSİS SJR Q1 JCR Q1 OpenAlex 75.8%
  11. 2011 Inhibitors of androgen receptor activation function 2 AF2 site identified through virtual screening JOURNAL OF MEDICINAL CHEMISTRY DOI 10.1021/jm200532b YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.0%
  12. 2011 Improvement of the expression and purification of Mycobacterium tuberculosis arylamine N acetyltransferase TBNAT a potential target for novel anti tubercular agents PROTEIN EXPRESSION AND PURIFICATION DOI 10.1016/j.pep.2011.06.021 YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.1%
  13. 2010 Characterization of a C C hydrolase from Mycobacterium tuberculosis involved in cholesterol metabolism JOURNAL OF BIOLOGICAL CHEMISTRY DOI 10.1074/jbc.M109.058081 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 92.7%
  14. 2009 Multiple routes of complement activation by Mycobacterium bovis BCG MOLECULAR IMMUNOLOGY DOI 10.1016/j.molimm.2009.07.015 YÖKSİS SJR Q2 JCR Q2 OpenAlex 89.3%
  15. 2009 Temperature stability of proteins essential for the intracellular survival of Mycobacterium tuberculosis Biochemical Journal DOI 10.1042/BJ20082011 YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.6%
  16. 2008 Arylamine N acetyltransferases in mycobacteria CURRENT DRUG METABOLISM YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.2%
  17. 2008 Structure of HsaD a steroid degrading hydrolase from Mycobacterium tuberculosis ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATION YÖKSİS SJR Q2 JCR Q4
  18. 2008 Arylamine N acetyltransferases structural and functional implications of polymorphisms TOXICOLOGY DOI 10.1016/j.tox.2008.08.022 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 95.0%
  19. 2007 Ocular defects associated with a null mutation in the mouse arylamine N acetyltransferase 2 gene MAMMALIAN GENOME YÖKSİS SJR Q1 JCR Q2 OpenAlex 82.6%
  20. 2005 A Pharmacokinetic Pharmacodynamic Model for the Mobilization of CD34 Hematopoietic Progenitor Cells by AMD3100 CLINICAL PHARMACOLOGY & THERAPEUTICS YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.0%

← Back to academicians